NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
The Crystal Serenity recently departed from Fort Lauderdale’s Port Everglades to kick off Crystal’s 2025 World Cruise. Sailing to South America, the Caribbean, the Atlantic and Europe, the 123-night ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback